Neurogene Inc. (NGNE) Business News Nov. 12, 2025, 21:02 UTC Neurogene Reports Positive Interim Data in Pediatric Cohort from NGN-401 Gene Therapy Trial for Rett Syndrome Full text
There are no comments here yet...